We are thrilled to welcome Dr. Paul McCracken to our Board of Directors. Many thanks to Susan Ruane, who recently served on our board representing ICON Clinical Research.

Dr. Paul McCracken, is the Vice President, Global Head of ICON Medical Imaging, and North Wales Site Head at ICON Plc.. Paul has over 20 years’ experience in imaging and pharmaceuticals, with a strong track record of applying imaging and biomarkers to drug discovery and development across a range of therapeutic areas. He joined ICON in 2016 having previously he founded and led the Imaging Centre of Excellence at Eisai Co.. Prior to Eisai, Paul worked at Merck Research Laboratories, where he developed preclinical and translational imaging biomarkers and strategies to assess new molecular and biologic entities. Paul holds a Bachelor of Science in Physics from The College of New Jersey, a Master of Science in Physics/Medical Physics from Wright State University and received his Ph.D. in Biomedical Engineering – Imaging from the Mayo Clinic College of Medicine.